Related Experiment Videos
The effects of 2-chloroadenosine and deoxycoformycin on the ATP level, Na-K ATPase activity in experimental brain
N Türközkan1, A Bilighan, B Cayci
1Department of Clinical Chemistry, Gazi University School of Medicine, Ankara, Turkey.
Abstract:
The effect of 2-chloroadenosine, stable adenosine analog, and deoxycoformycin, adenosine deaminase inhibitor on brain ATP level and Na-K ATPase activity in ischemia were studied. The brain ATP level was increased after we administered both 2-chloroadenosine and deoxycoformycin, but Na-K ATPase activity did not change after deoxycoformycin. The results suggest that 2-chloroadenosine treatment influenced both the ATP production and membrane permeability due to cerebral ischemia. Deoxycoformycin did not protect the membrane permeability, although it increased the ATP production.
Insights
2-chloroadenosine and deoxycoformycin boosted brain ATP levels during ischemia. However, only 2-chloroadenosine improved membrane permeability, suggesting its broader protective effects against cerebral ischemia.
Area of Science:
- Neuroscience
- Biochemistry
- Pharmacology
Background:
- Cerebral ischemia leads to decreased brain ATP levels and impaired Na-K ATPase activity.
- Adenosine analogs and deaminase inhibitors are potential therapeutic agents for ischemic conditions.
Purpose of the Study:
- To investigate the effects of 2-chloroadenosine and deoxycoformycin on brain ATP levels and Na-K ATPase activity during ischemia.
- To determine the potential neuroprotective mechanisms of these compounds in cerebral ischemia.
Main Methods:
- Administration of 2-chloroadenosine (adenosine analog) and deoxycoformycin (adenosine deaminase inhibitor) in an ischemic model.
- Measurement of brain ATP levels.
- Assay of Na-K ATPase activity.
Main Results:
- Both 2-chloroadenosine and deoxycoformycin increased brain ATP levels in ischemia.
- Deoxycoformycin did not alter Na-K ATPase activity.
- 2-chloroadenosine treatment influenced both ATP production and membrane permeability.
Conclusions:
- 2-chloroadenosine demonstrates potential in mitigating cerebral ischemia by enhancing ATP production and preserving membrane permeability.
- Deoxycoformycin increases ATP production but does not protect membrane permeability, suggesting a limited therapeutic role in ischemia compared to 2-chloroadenosine.